期刊文献+

钙黏蛋白-13表达下调对膀胱癌细胞上皮间质转化的影响

The effect of CDH13 down-regulation on the epithelial mesenchymal transition of bladder cancer cells
下载PDF
导出
摘要 目的研究CDH13表达下调对膀胱癌5637细胞上皮间质转化的影响。方法应用RNA干扰技术抑制膀胱癌5637细胞中CDH13的表达后,倒置相差显微镜下观察细胞形态的变化,Western blot检测CDH13及上皮间质转化标志物E-钙黏蛋白、N-钙黏蛋白和α-平滑肌动蛋白的表达。结果膀胱癌5637细胞中CDH13表达下调后细胞形态向间质细胞转变,呈现长梭形,细胞间紧密连接松散,大多数细胞出现细长的丝状伪足;上皮细胞标志物E-钙黏蛋白表达减少(P<0.05),间质细胞标志物N-钙黏蛋白和α-平滑肌动蛋白表达增加(P<0.05),与对照组相比差异有统计学意义。结论膀胱癌细胞中CDH13表达下调促进肿瘤细胞向间质细胞转化。 Objective To investigate the effect of CDH13 down-regulation on the epithelial mesenchymal transition of bladder cancer cells.Methods After CDH13 expression in 5637 cells was inhibited with RNA interference,the changes of cell morphology were observed using inverted phase contrast microscope.The expression of CDH13,E-cadherin,N-cadherin andα-smooth muscle actin were examined using Western blot.Results After the down-regulation of CDH13 expression in bladder cancer 5637 cells,the cells transited to fusiform mesenchymal-like cells,the tight intercellular connection became loose,and most cells showed slender filopodia.The expression of epithelial cell marker E-cadherin decreased(P〈0.05),while the expression of N-cadherin andα-smooth muscle actin increased(P〈0.05),and the differences were statistically significant compared with the control.Conclusion Down-regulation of CDH13 expression promotes the process of epithelial mesenchymal transition of bladder cancer cells.
出处 《现代泌尿外科杂志》 CAS 2016年第5期387-390,共4页 Journal of Modern Urology
基金 徐州市医学青年后备人才项目(No:2014007) 徐州市科技计划项目(No:KC14SH015) 江苏大学临床科技发展基金项目(No:JLY20140109) 江苏省"六大人才高峰"资助项目(2014-WSW-066) 江苏省卫计委青年科研课题项目No:(Q201514)
关键词 膀胱癌 CDH13 上皮间质转化 bladder cancer CDH13 epithelial mesenchymal transition
  • 相关文献

参考文献17

  • 1PIGNOT G, LE GOUX C, BIECHE I.Recent advances in bladder urothelial carcinogenesis [J].Bull Cancer,2015,102(12):1020-1035.
  • 2HARSHMAN LC, PRESTON MA, BELLMUNT J, et al.Diagnosis of bladder carcinoma: a clinician's perspective [J].Surg Pathol Clin,2015,8(4):677-685.
  • 3SCARPATO KR, MORGANS AK, MOSES KA.Optimal management of muscle-invasive bladder cancer -a review [J].Res Rep Urol,2015,7(1):143-151.
  • 4MIYATA Y, SAKAI H.Predictive markers for the recurrence of nonmuscle invasive bladder cancer treated with intravesical therapy [J].Dis Markers,2015,2015(1):857416.
  • 5ZHONG YH, PENG H, CHENG HZ, et al.Quantitative assessment of the diagnostic role of CDH13 promoter methylation in lung cancer[J].Asian Pac J Cancer Prev,2015,16(3):1139-1143.
  • 6林英立,管同郁,向代香,孙光.膀胱癌组织中CDH13的表达及临床意义[J].国际泌尿系统杂志,2013,33(5):594-596. 被引量:6
  • 7LIN YL, SUNG G, LIU X, et al.Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma [J].Urol Int,2011,86(3):340-345.
  • 8林英立,管同郁,戚景光,梁杰,孙光.siRNA抑制CDH13表达对膀胱癌5637细胞增殖和侵袭的影响[J].国际泌尿系统杂志,2014,34(2):147-150. 被引量:8
  • 9LIN YL, HE ZK, LI ZG, et al.Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma [J].Urol Int,2013,90(2):225-232.
  • 10YE X, WEINBERG RA.Epithelial-mesenchymal plasticity: A central regulator of cancer progression[J].Trends Cell Biol,2015,25(11):675-686.

二级参考文献18

  • 1Lee SW.H-cadherin,a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer.Nat Med,1996,2 (7):776-782.
  • 2Mukoyama Y,Zhou S,Miyachi Y,et al.T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells.J Invest Dermato1,2005,124 (4):833-838.
  • 3Yan Q,Zhang ZF,Chen XP,et al.Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.Int J Oncol,2008,32(5):1057-1063.
  • 4Kuphal S,Martyn AC,Pedley J,et al.H-cadherin expression reduces invasion of malignant melanoma.Pigment Cell Melanoma Res,2009,22 (3):296-306.
  • 5Chan DW,Lee JM,Chant PC,et al.Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.Int J Cancer,2008,123(5):1043-1052.
  • 6van Phijn BW,Burger M,Lotan Y,et al.Recurrence and progression of disease in non-muscle-invasive bladder cancer:from epidemiology to treatment strategy.Eur Urol,2009,56(3):430-442.
  • 7Ploeg M,Aben KK,Kiemeney LA.The present and future burden of urinary bladder cancer in the world..World J Urol,2009,27(3):289-293.
  • 8Philippova M,Joshi MB,Kyriakakis E,et al.A guide and guard:the many faces of T-cadherin.Cell Signal,2009,21(7):1035-1044.
  • 9Virmani AK,Gazdar AF.Tumor suppressor genes in lung cancer.Methods Mol Biol,2003,2229(1):97-115.
  • 10Schwentner C,Stenzl A,Gakis G.Monitoring high-risk bladder cancer[J].Curr Opin Urol,2012,22(5):421-426.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部